Skip to main content
Arcellx, Inc. (ACLX)
NASDAQ: ACLX · Real-Time Price · USD
79.02
+1.44 (1.86%)
At close: Dec 26, 2024, 4:00 PM
79.40
+0.38 (0.48%)
Pre-market: Dec 27, 2024, 8:01 AM EST

Arcellx Revenue

Arcellx had revenue of $26.03M in the quarter ending September 30, 2024, with 74.03% growth. This brings the company's revenue in the last twelve months to $155.82M, up 230.33% year-over-year. In the year 2023, Arcellx had annual revenue of $110.32M.

Revenue (ttm)
$155.82M
Revenue Growth
+230.33%
P/S Ratio
26.50
Revenue / Employee
$1,198,600
Employees
130
Market Cap
4.27B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2023110.32M--
Dec 31, 2022---
Dec 31, 2021---
Dec 31, 2020---
Dec 31, 2019---
Dec 31, 2018 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Integer Holdings 1.71B
Prestige Consumer Healthcare 1.11B
Apellis Pharmaceuticals 715.22M
Guardant Health 692.26M
Ultragenyx Pharmaceutical 522.75M
ADMA Biologics 382.81M
Axsome Therapeutics 338.46M
Krystal Biotech 241.52M
Revenue Rankings

ACLX News

More News